OpenBilldrug price receipt

NADAC week of 2026-10-14

CAPECITABINE 500 MG TABLET

For 30 tablets

Pharmacies pay

$13.67 filed

30 × $0.45556 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$8.70 derived

30 × $0.29 per EA, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

0.64× estimated

Medicare pays 36% less than pharmacies pay.

13 labelers share HCPCS J8522 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$20.72 estimated

$13.67 + $2.05 (15%) + $5.00 fee per fill = $20.72

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CAPECITABINE 500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as capecitabine.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Accord Healthcare Inc. and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Nucleoside Metabolic Inhibitor.

The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 15 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $13.67 for 30 tablets (30 × $0.45556 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 14 labelers

LabelerNDCsPharmacies pay per unit
Camber Pharmaceuticals, Inc.2$0.45556 per EA filed
Accord Healthcare Inc.1$0.45556 per EA filed
American Health Packaging1$0.45556 per EA filed
Ascend Laboratories, LLC1$0.45556 per EA filed
Aurobindo Pharma Limited1$0.45556 per EA filed
BluePoint Laboratories1$0.45556 per EA filed
Cipla USA Inc.1$0.45556 per EA filed
CivicaScript LLC1$0.45556 per EA filed
Dr. Reddy's Laboratories Limited1$0.45556 per EA filed
Lifestar Pharma LLC1$0.45556 per EA filed
NorthStar RxLLC1$0.45556 per EA filed
Novadoz Pharmaceuticals LLC1$0.45556 per EA filed
Quallent Pharmaceuticals Health LLC1$0.45556 per EA filed
Teva Pharmaceuticals USA, Inc.1$0.45556 per EA filed
Not listed as a package in the FDA directory2$0.45556 per EA filed
All 17 NDCs, with labeler and price
  • 00093-7474-89 · Teva Pharmaceuticals USA, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
  • 16729-0073-29 · Accord Healthcare Inc. · $0.45556 per EA · eff. 2026-09-23 filed
  • 31722-0775-12 · Camber Pharmaceuticals, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
  • 31722-0775-60 · Camber Pharmaceuticals, Inc. · $0.45556 per EA · eff. 2026-09-23 filed
  • 55111-0497-04 · Dr. Reddy's Laboratories Limited · $0.45556 per EA · eff. 2026-09-23 filed
  • 59651-0205-08 · Aurobindo Pharma Limited · $0.45556 per EA · eff. 2026-09-23 filed
  • 60687-0149-11 · not listed as a package in the FDA directory · $0.45556 per EA · eff. 2026-09-23 filed
  • 60687-0149-94 · American Health Packaging · $0.45556 per EA · eff. 2026-09-23 filed
  • 62135-0784-12 · not listed as a package in the FDA directory · $0.45556 per EA · eff. 2026-09-23 filed
  • 67877-0459-12 · Ascend Laboratories, LLC · $0.45556 per EA · eff. 2026-09-23 filed
  • 68001-0644-07 · BluePoint Laboratories · $0.45556 per EA · eff. 2026-09-23 filed
  • 69097-0948-08 · Cipla USA Inc. · $0.45556 per EA · eff. 2026-09-23 filed
  • 70756-0816-22 · Lifestar Pharma LLC · $0.45556 per EA · eff. 2026-09-23 filed
  • 72205-0007-92 · Novadoz Pharmaceuticals LLC · $0.45556 per EA · eff. 2026-09-23 filed
  • 72603-0303-01 · NorthStar RxLLC · $0.45556 per EA · eff. 2026-09-23 filed
  • 82009-0112-12 · Quallent Pharmaceuticals Health LLC · $0.45556 per EA · eff. 2026-09-23 filed
  • 82249-0210-12 · CivicaScript LLC · $0.45556 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name capecitabine with CAPECITABINE 500 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
CAPECITABINE 150 MG TABLET
generic · tablet, film coated / tablet
$0.36154 per EA filed
eff. 2026-06-17
$0.087 per EA derived
Part B limit 2026 Q4
CAPECITABINE 500 MG TABLET this page
generic · tablet, film coated / tablet
$0.45556 per EA filed
eff. 2026-09-23
$0.29 per EA derived
Part B limit 2026 Q4

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J8522, for 2026-10-01 to 2026-12-31, comes to $8.70 for 30 tablets, or $0.29 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for this oral drug at a pharmacy only in specific circumstances CMS sets for this code; most prescriptions are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0058 per 50 MG.

11 of the product’s 17 NDCs have this Medicare figure; the other 6 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.